Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
about
Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitorsThe Role of Hedgehog Signaling in Tumor Induced Bone DiseaseCooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapyHedgehog signaling inhibitors as anti-cancer agents in osteosarcomaHedgehog signaling pathway in ovarian cancerHedgehog signaling pathway and its targets for treatment in basal cell carcinomaSmoothened variants explain the majority of drug resistance in basal cell carcinomaSonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinomaUV radiation and the skinDeficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesisPTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation.The vitamin D receptor: a tumor suppressor in skin.Vitamin D and the skin: Physiology and pathophysiology.NAV3 copy number changes and target genes in basal and squamous cell cancers.Expression of microRNAs in basal cell carcinoma.Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease.Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.Common critical pathways in embryogenesis and cancer.From the bench to emerging new clinical concepts: Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancerMutational analysis of hedgehog signaling pathway genes in human malignant mesotheliomaVitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomasIntegrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological featuresHedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cellsTazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.Clinical implications of hedgehog signaling pathway inhibitorsIdentification of signature genes for detecting hedgehog signaling activation in gastric cancer.Identification of signature genes for detecting hedgehog pathway activation in esophageal cancer.The hedgehog/Gli signaling paradigm in prostate cancerBasal cell carcinoma-treatments for the commonest skin cancer.Frequency and features of TP53 mutation in 30 Chinese patients with sporadic basal cell carcinoma.Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant micePhotodynamic therapy for Basal cell carcinoma in recessive dystrophic epidermolysis bullosaBasal cell carcinomas: attack of the hedgehog.Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: an integrative molecular and surgical case study.The Hedgehog pathway: role in cell differentiation, polarity and proliferation
P2860
Q24657777-97199661-3602-4F35-B0E2-223B5DC79668Q26775917-23B0D27B-60E9-4C62-ABBD-28A2A63740D8Q26783615-1E29FB2F-B2F5-499D-8B99-F28CA3F43E80Q26865136-FFFD58CA-C1E5-45DE-B4D9-A0B5548511C9Q26992348-2114ADC3-02A9-420D-A760-748F5B0651C2Q26995487-524FB155-D09D-47A5-B252-8A7F703CE784Q27021460-54A1E43A-BEAD-4EFA-B715-AE546E4C8458Q27853140-765CF1CA-EB7F-447B-97CA-9C540D8A4095Q28078947-4A9CA929-8173-4CBC-A4E7-B4FD8492A524Q28292301-864ED35C-847F-4267-B915-5408A6B8AF8CQ28389106-F6ACA364-A36A-4397-ADAD-20E3D23F55F0Q33418311-F1DE469E-FD54-47EE-AE3F-25BC7C450F64Q33718913-369DE77B-E6C9-40B2-9510-5D86CFAFE52DQ33806485-D5E77DDD-14F3-4424-92EB-DCD2E58E6963Q33993788-D0B7CA96-9FB9-4E05-B8F6-69D14CCD0468Q34223963-4D5D9334-9DFF-4A49-949E-3B16976E1691Q34271420-6D8ACCF8-2C2C-44FD-9FE2-4476E3D37959Q34495423-E756C70B-13A7-4770-B924-4AB8A02ECAE6Q34532204-90FD80F5-7C84-410C-8623-2DC53B10075DQ34535747-A60356F7-B248-4D75-8B24-E52E8A225BD1Q34637963-6E54D6E3-1223-48F8-8A57-69AA07893B25Q34795828-53987EF6-5C4D-48FF-B1B3-7013E4DAEFDDQ34939822-591CF9A9-10FC-4744-A9CE-7F93A110B65CQ34948316-66292EBA-D697-4FCE-B369-CD71DEFD38F7Q34995035-1823A3F9-8791-47EA-AEE9-1FE528C54881Q35068938-E9E5C6A4-FBB6-465C-9346-6632BB1B2D74Q35108046-2476F63A-95CC-4209-A1ED-F8BBFDFEFD2EQ35108082-58E139CB-AB0F-47DA-BC2F-9ED7C3EE4F23Q35108140-192F3EF4-31E0-4217-A8BA-A17D16902FB7Q35109835-A776689D-F43B-4A83-B3C2-8180D55CB2E8Q35198596-6F99FC16-C301-44FE-A7DA-00071D77660EQ35241457-D3FDA7E7-79DC-44F1-A98F-7FBEB99DFDC0Q35603713-444BC8BE-4406-4071-8315-E8EB29FC4CE1Q35605827-0C5F7BF6-6E58-4D5A-956A-CD71DAC59FA4Q35684352-93C23EEE-639A-438F-BD65-1685A7952CBCQ35687900-059B0F64-6671-4804-94EC-71B0A2E1BE63Q35756696-45DF7BAE-12CB-496A-8007-A2A34B8BB2BAQ35771697-F022BEB6-43EE-4C5C-96E4-5D5172996E1EQ35844631-0AD82442-1563-41E4-98BF-4173C1E45F2CQ36240079-66DE07C3-C111-4EBD-B8EE-3C3EFBFA3848
P2860
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@en
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@nl
type
label
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@en
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@nl
prefLabel
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@en
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@nl
P2093
P1476
Somatic mutations in the PTCH, ...... poradic basal cell carcinomas.
@en
P2093
A Schönicke
B Blaschke
C B Knobbe
C Scharwächter
G Reifenberger
J Reifenberger
P356
10.1111/J.1365-2133.2005.06353.X
P407
P577
2005-01-01T00:00:00Z